KiOmed Pharma

medical devices

About

KiOmed Pharma is a Belgian biotechnology company that develops, manufactures, and distributes innovative medical devices using a unique, non-animal-derived chitosan chemistry. As a spinout from KitoZyme, the company focuses on addressing significant medical needs in areas such as osteoarthritis, skin aging, and ophthalmology. The company's proprietary technology platform, KiOmedine®, employs a biodegradable chitosan biopolymer to create effective therapeutic solutions. One of its key products is KioMedine(vs)one, a single-injection soft implant designed to alleviate pain and enhance mobility for patients with knee osteoarthritis. This product is available in Europe and is also being developed for the Chinese market through a licensing agreement with Hansoh Pharmaceutical Group. KiOmed Pharma is committed to biocompatibility and safety, ensuring its formulations are derived from non-animal sources. Headquartered in Herstal, Liège, Belgium, KiOmed Pharma is led by CEO Houtaï Choumane and employs a dedicated team. The company aims to improve patient outcomes through its innovative medical devices and has established strategic partnerships to expand its global reach.

Technologies

OutlookMicrosoft Office 365reCAPTCHAVarnishApacheWordPress.orgVimeoMobile FriendlyRemote

Keywords

rheumatology joint healthdermatologyregenerative medicinebiosurgeryanimalfree chitosanmedical devices implantsbiomaterialsultrapure chitosanrheumatology amp joint healthmedical devices amp implantsmedical equipment manufacturingmedical equipment and supplies manufacturingoxidative stress protectionclinical valuebiotechtissue protectionmedical devicesbiopolymerregulatory approvalmanufacturingb2brefractory osteoarthritisbiotechnologypharmaceuticalscm-chitosanchitosansustainable attributeseye dropshealthcaredermal fillers

Location

4 Rue Haute Marexhe, Herstal, Walloon Region, Belgium, 4040

Related Companies

Companies in the same industry